The Pt(ii) α-diimine complexes [PtCl2κ2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3; 4-C6H4OH, 4) and [PtCl2κ2N-(CH3CNOH)2] (5) were prepared in 60-81% yields from the 1 : 1 molar reactions of cis-[PtCl2(DMSO)2] with the appropriate α-diimine, [HCN(R)]2 (R = C6H11, L1; 4-C6H10OH, L2; 4-C6H4Me, L3; 4-C6H4OH, L4), or dimethylglyoxime (dmgH2), in acetone at reflux. The reaction of cis-[PtCl2(DMSO)2] with two molar equivalents of dmgH2 and NEt3 in methanol at reflux afforded the bis-dimethylglyoximato compound [Ptκ2N,N′-(ON═C(CH3)C(CH3)═NOH)2], [Pt(dmgH)2], as an insoluble material, in 97% yield. The oxalato derivative [Pt(κ2O-C2O4)κ2N-(HCN(C6H11))2], 6, was obtained from the sequential treatment of 1 with AgNO3 and Na2C2O4, in 61% yiel...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Three novel cisplatin analogues were synthesized, designed according to an approach which violates t...
A group of new Pt(II) complexes with dichloroacetate (DCA), bearing DMSO (cis-[Pt(DCA)2(Me2SO-S)2], ...
The Pt(ii) α-diimine complexes [PtCl2κ2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3; 4-C6H4O...
The Pt(ii) α-diimine complexes [PtCl2κ2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3; 4-C6H4O...
The Pt(ii) \u3b1-diimine complexes [PtCl2\u3ba2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3;...
Since the discovery of the antitumor activity of cisplatin, many studies have been devoted to unders...
Mono(nucleobase) complexes of the general composition cis-[PtCl(NH)L] with L=1-methylcytosine, 1-MeC...
The title compounds were prepared from ethyl cyanoacetate by the four-step procedure of conversion i...
Starting from the [PtCl(η1-C2H4OMe)(phen)] (phen = 1,10-phenanthroline, 1) platinum(II) precursor, w...
Mono(nucleobase) complexes of the general composition cis-[PtCl2(NH3)L] with L=1-methylcytosine, 1-M...
© 2020, Society for Biological Inorganic Chemistry (SBIC). Abstract: The search for more effective p...
The coordination chemistry of the antitumor agent cisplatin and related complexes with DNA and its c...
Abstract Three new series of homoleptic and heteroleptic platinum(II) β‐oxodithiocinnamic ester comp...
Platinum complexes, bearing aliphatic amines and phosphine ligands in trans configuration with iodid...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Three novel cisplatin analogues were synthesized, designed according to an approach which violates t...
A group of new Pt(II) complexes with dichloroacetate (DCA), bearing DMSO (cis-[Pt(DCA)2(Me2SO-S)2], ...
The Pt(ii) α-diimine complexes [PtCl2κ2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3; 4-C6H4O...
The Pt(ii) α-diimine complexes [PtCl2κ2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3; 4-C6H4O...
The Pt(ii) \u3b1-diimine complexes [PtCl2\u3ba2N-(HCNR)2] (R = C6H11, 1; 4-C6H10OH, 2; 4-C6H4CH3, 3;...
Since the discovery of the antitumor activity of cisplatin, many studies have been devoted to unders...
Mono(nucleobase) complexes of the general composition cis-[PtCl(NH)L] with L=1-methylcytosine, 1-MeC...
The title compounds were prepared from ethyl cyanoacetate by the four-step procedure of conversion i...
Starting from the [PtCl(η1-C2H4OMe)(phen)] (phen = 1,10-phenanthroline, 1) platinum(II) precursor, w...
Mono(nucleobase) complexes of the general composition cis-[PtCl2(NH3)L] with L=1-methylcytosine, 1-M...
© 2020, Society for Biological Inorganic Chemistry (SBIC). Abstract: The search for more effective p...
The coordination chemistry of the antitumor agent cisplatin and related complexes with DNA and its c...
Abstract Three new series of homoleptic and heteroleptic platinum(II) β‐oxodithiocinnamic ester comp...
Platinum complexes, bearing aliphatic amines and phosphine ligands in trans configuration with iodid...
The first platinum-based drug was discovered and approved by Food and Drug Administration (FDA) in 1...
Three novel cisplatin analogues were synthesized, designed according to an approach which violates t...
A group of new Pt(II) complexes with dichloroacetate (DCA), bearing DMSO (cis-[Pt(DCA)2(Me2SO-S)2], ...